awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38984960-F76855BB-4EF1-46C0-B69E-24736BC1C3D8
Q38984960-F76855BB-4EF1-46C0-B69E-24736BC1C3D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38984960-F76855BB-4EF1-46C0-B69E-24736BC1C3D8
The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells.
P2860
Q38984960-F76855BB-4EF1-46C0-B69E-24736BC1C3D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38984960-F76855BB-4EF1-46C0-B69E-24736BC1C3D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82f6cf967ba5d566e7d17ab981bf515752cd0faa
P2860
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500 mg/m(2) every 21 days in patients with cancer